Donna Turner

15.2k total citations · 1 hit paper
80 papers, 2.4k citations indexed

About

Donna Turner is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Donna Turner has authored 80 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 15 papers in Public Health, Environmental and Occupational Health and 12 papers in Epidemiology. Recurrent topics in Donna Turner's work include Colorectal Cancer Screening and Detection (35 papers), Global Cancer Incidence and Screening (35 papers) and Gastric Cancer Management and Outcomes (8 papers). Donna Turner is often cited by papers focused on Colorectal Cancer Screening and Detection (35 papers), Global Cancer Incidence and Screening (35 papers) and Gastric Cancer Management and Outcomes (8 papers). Donna Turner collaborates with scholars based in Canada, United States and Australia. Donna Turner's co-authors include Harminder Singh, Lin Xue, Çharles N. Bernstein, Alain Demers, Laura E. Targownik, Ryan Woods, Darren R. Brenner, Larry F. Ellison, Rob Sanson‐Fisher and Hannah K. Weir and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Donna Turner

78 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Projected estimates of cancer in Canada in 2022

2022 184 citations Darren R. Brenner, Ryan Woods et al. Canadian Medical Association Journal profile →

Peers

Countries citing papers authored by Donna Turner

Since Specialization

Citations

This map shows the geographic impact of Donna Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Turner more than expected).

Fields of papers citing papers by Donna Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Turner. The network helps show where Donna Turner may publish in the future.

Co-authorship network of co-authors of Donna Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Turner. A scholar is included among the top collaborators of Donna Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Turner. Donna Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Frequency of Missing TNM Stage Data for Adults With Intellectual or Developmental Disabilities in a Provincial Cancer Registry—A Brief Report 2025 ·Cancer Medicine ·(unknown), Hélène Ouellette‐Kuntz, Rebecca Griffiths, (unknown), Julie Hallet, Christine Kelly, Kathleen Decker, David E. Dawe, Shahin Shooshtari, Marni Brownell, Donna Turner, Virginie Cobigo, Alyson Mahar	1
2	Impact of age, comorbidity, and polypharmacy on receipt of systemic therapy in advanced cancers: A retrospective population-based study 2024 ·Journal of Geriatric Oncology ·(unknown), Kathleen Decker, Pascal Lambert, (unknown), Philip St. John, Donna Turner, Piotr Czaykowski, David E. Dawe	3
3	Stage IV breast, colorectal, and lung cancer at diagnosis in adults living with intellectual or developmental disabilities: A population‐based cross‐sectional study 2023 ·Cancer ·Alyson Mahar, (unknown), (unknown), Shelley Derksen, Rebecca Griffiths, Jennifer Enns, David E. Dawe, Julie Hallet, (unknown), Kathleen Decker, Virginie Cobigo, Shahin Shooshtari, (unknown), Christine Kelly, Marni Brownell, Donna Turner, Hélène Ouellette‐Kuntz	11
4	Patient and family financial burden associated with cancer treatment in Canada: a national study 2021 ·Supportive Care in Cancer ·Christopher J. Longo, Margaret I. Fitch, Jonathan M. Loree, Linda E. Carlson, Donna Turner, Winson Y. Cheung, Darin Gopaul, Janet Ellis, Jolie Ringash, Maria Mathews, James R. Wright, Christiaan Stevens, David D’Souza, Robin Urquhart, Tuhin Maity, (unknown), (unknown)	56
5	Examining the Impact of First Nations Status on the Relationship Between Diabetes and Cancer 2020 ·Health Equity ·Kathleen Decker, Pascal Lambert, Alain Demers, Erich V. Kliewer, Grace Musto, (unknown), Brenda Elias, Donna Turner	1
6	Projected estimates of cancer in Canada in 2020 2020 ·Canadian Medical Association Journal ·Darren R. Brenner, Hannah K. Weir, Alain Demers, Larry F. Ellison, C. Louzado, Amanda Shaw, Donna Turner, Ryan Woods, Leah Smith	263
7	Examining the Selection Criteria of Neoadjuvant Chemotherapy Patients 2017 ·Journal of Obstetrics and Gynaecology Canada ·(unknown), Pascal Lambert, Donna Turner, Robert Lotocki, Erin Dean, (unknown), Alon D. Altman, Mark W. Nachtigal	2
8	Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer 2017 ·International Journal of Gynecological Cancer ·Alon D. Altman, Pascal Lambert, (unknown), Donna Turner, Robert Lotocki, Erin Dean, (unknown), Mark W. Nachtigal	20
9	Primary care physician use across the breast cancer care continuum: CanIMPACT study using Canadian administrative data. 2016 ·PubMed ·(unknown), Aïsha Lofters, Rahim Moineddin, Kathleen Decker, Patti A. Groome, Cynthia Kendell, Monika K. Krzyzanowska, Dongdong Li, Mary L. McBride, Nicole Mittmann, Geoff Porter, Donna Turner, Robin Urquhart, Marcy Winget, Yang Zhang, Eva Grunfeld	16
10	Primary care physician use across the breast cancer care continuum 2016 ·Canadian Family Physician ·(unknown), Aïsha Lofters, Rahim Moineddin, Kathleen Decker, Patti A. Groome, Cynthia Kendell, Monika K. Krzyzanowska, Dongdong Li, Mary L. McBride, Nicole Mittmann, Geoff Porter, Donna Turner, Robin Urquhart, Marcy Winget, Yang Zhang, Eva Grunfeld	2
11	An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation 2016 ·BMJ Open ·David Weller, Peter Vedsted, Chantelle Anandan, (unknown), Evangelia Ourania Fourkala, (unknown), (unknown), Henry Jensen, Andriana Barisic, Anna Gavin, Eva Grunfeld, Mats Lambe, Rebecca‐Jane Law, Martin Malmberg, Richard D Neal, Jatinderpal Kalsi, Donna Turner, Victoria White, Martine Bomb, Usha Menon	36
12	Using personal health insurance numbers to link the Canadian Cancer Registry and the Discharge Abstract Database. 2015 ·PubMed ·Dianne Zakaria, (unknown), Claudia Sanmartin, (unknown), (unknown), (unknown), Donna Turner, Brandon Wagar, (unknown), K.A. Vriends, Ryan Woods, Gina Lockwood, R. Louchini	2
13	Does young age influence the prognosis of colorectal cancer: a population-based analysis 2014 ·World Journal of Surgical Oncology ·Andrew McKay, (unknown), Ramzi M. Helewa, Jason Park, Debrah Wirtzfeld, David Hochman, Harminder Singh, Donna Turner	68
14	Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: results from a pragmatic cluster randomized controlled trial 2014 ·BMC Cancer ·(unknown), (unknown), Alan Katz, Patricia J. Martens, Jeff Sisler, Donna Turner, Michelle Lobchuk, Susan McClement, G. H. Crow	13
15	Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol 2012 ·BMC Cancer ·(unknown), (unknown), Alan Katz, Patricia J. Martens, Jeff Sisler, Donna Turner, Michelle Lobchuk, Susan McClement	5
16	Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study 2011 ·PLoS ONE ·Salaheddin M. Mahmud, Eduardo L. Franco, Donna Turner, Robert W. Platt, Patricia Beck, David Skarsgard, Jon Tonita, Colin Sharpe, Armen Aprikian	42
17	Long-Term Use of Statins and Risk of Colorectal Cancer 2009 ·The American Journal of Gastroenterology ·Harminder Singh, Salaheddin M. Mahmud, Donna Turner, Lin Xue, Alain Demers, Çharles N. Bernstein	53
18	994 Long-Term Users of Statins Are Not Protected Against Colorectal Cancer 2008 ·Gastroenterology ·Harminder Singh, Donna Turner, Salaheddin M. Mahmud, Lin Xue, Anita L. Kozyrskyj, Alain Demers, Çharles N. Bernstein	1
19	Methodological issues in the development of theCanadian Cancer Incidence Atlas 2000 ·Statistics in Medicine ·R Semenciw, Nhu D. Le, Loraine D. Marrett, Diane Robson, Donna Turner, Stephen D. Walter	9
20	Anergy--a prognostic indicator in early breast cancer. 1978 ·BMJ ·A R Turnbull, Donna Turner, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact